Blogs

Categories

Select a Sub-Category

Films and Coatings
Pharmaceutical Packaging Components
Prefillable Systems
Self Injection Devices
Vial Containment Solutions
Washing and Sterilization
Reconstitution and Transfer Devices

Select a Sub-Category

Analytical Lab Services
Contract Manufacturing
Fill-Finish
Regulatory Support

Select a Sub-Category

Cell and Gene Therapy Packaging
Drug Development Process
Regulatory Challenges
Transitioning to Combination Products

Select a Sub-Category

Corporate Development
ESG/Sustainability
One West Team (Employee Culture)
Our Culture of Giving (Philanthropy)
Research and Development

Previous Blogs

By Your Side for Collaboration
Biosimilar Companies FDA Guidance West By Your Side Simplify the Journey
New FDA Guidance on “Considerations in Demonstrating Interchangeability with a Reference Product” – How West is Working to Support Biosimilar Companies

By Victoria Morgan

十月 10, 2019

The development of new biosimilar products has increased over the past several years. Europe and Asia Pacific have been leading the industry with the greatest number of biosimilars being introduced to the market. Given the demand to reduce medical costs for patients, this trend is expected to increase globally in the coming years.

Read More
A girl Smiling with her dog
Animal Health Elemental Impurities FDA Guidance
FDA Guidance on Elemental Impurities Affects Animal Health Customers

By West's Marketing Team

七月 30, 2018

Elemental impurities, such as arsenic, cadmium, lead and mercury are ubiquitous in nature. They are also toxic to humans and animals at certain levels. Because these elements are often part of mined minerals used in the manufacture of drug products and/or drug containment systems, they can have an impact on the quality of a drug.

Read More